Conatus Pharmaceuticals Inc. (CNAT)

[chainma1l]

Earnings today weren't bad. They have enough cash for a year and a lot of stuff going on. May be a while before they really take off, but I think they are in great shape for the stage they are at. Low float, so even if they have to raise some money it's not going to kill shareholders. Biotech as a whole seems to be getting some attention now, so hopefully CNAT's SP will rise with that tide. Based on comparables, I think the current SP is low. Buyout is probably cheaper than a partnership at this point.
I've been meaning to revisit INO. Check out ADXS, if you haven't recently.